MC2 Capital


Please note that applications closed on October 31, 2022.

Receive an investment of up to $400,000 CAD from CABHI to grow and scale your healthtech or fintech solution.

Eligible companies may access additional investment of up to $400,000 CAD from the Ontario Brain Institute, commercialization and funding support from Ontario Bioscience Innovation Organization, and business financing from Clearco.

As a hands-on investor, we provide you with access to acceleration services to further grow and scale your company:

rocketship graphic

Tap into a 200+ network of distribution channels and industry organizations.

graphic: four arms interlocked

Meet our 100+ subject matter experts in healthcare, industry, venture capital, and more.

graphic: dollar sign

Receive financing, legal, and regulatory benefits and discounts through our corporate partners.

speaker-graphic

Customer Discovery

Unlock end-user testing and customer discovery to increase sales.

icons-suitcase

Student Placements

Benefit from 100% subsidized internships and co-op placements.

Why CABHI

Picture of women discussing project

Since its inception, CABHI has helped companies acquire customers, grow revenues, expand sales pipelines, incorporate in new jurisdictions, and obtain carry-on investments (including seed, series A, and debentures).

The Scientific Officer Program – Researchers from scientific networks and partner organizations are matched with CABHI’s innovators and companies through the Scientific Officer (SO) Program. Researchers provide scientific advice and expertise to CABHI-supported innovators to enhance the rigour of validation trials to help innovators refine their value proposition.

Community of Practice – CABHI served as a founding member in the emerging Community of Practice (CoP) amongst Ontario-funded research and innovation organizations. CABHI plans to play a similarly active and engaged role in the CoP, providing staffing resources, infrastructure (e.g., physical space, the interactive Leap platform, design thinking and Knowledge Mobilization services, etc.) to ensure the greatest possible success and impact from the group. CABHI expects new partnerships to emerge from the CoP, and also plans to share learnings and best practices with groups beyond the CoP.

To date, CABHI innovators and companies have secured more than $400M CAD in carry-on investments and more than 50% of CABHI companies have received follow-on funding.

CABHI alumni include:

  • Digital physical therapy provider Sword Health, which recently attained unicorn status (valued at $2B)
  • Virtual care platform Akira Health, acquired by TELUS Health
  • Neurohealth technology company BrainFx, acquired by Highmark Innovations, Inc

Let us help you #getmarketready

Who You Are

Your early-stage company:

  • Seeks investment capital to grow and scale
  • Has a healthtech or fintech solution to improve the lives of aging adults
  • Meets one or more of CABHI’s five Innovation Themes

Access Your Capital

Canadian healthtech and fintech companies face an early-stage funding gap. CABHI helps close this gap by enabling access to buyers, subject matter experts, and international markets,
such as those in the US, Japan, or UK.

Each participating company will receive an investment of up to $400,000 CAD and access to CABHI’s Acceleration Services and the Ontario Bioscience Innovation Organization’s capital access resources to help grow and scale their solution.

Plus, eligible companies may access additional investment up to $400,000 from the Ontario Brain Institute, commercialization and funding support from Ontario Bioscience Innovation Organization, and business financing from Clearco. 

Companies may also access additional investment opportunities through CABHI’s investor community. 

What Our Companies Say about CABHI

Ken Deering

KEN DEERING
CEO, iGuard Home Solutions

“CABHI’s investment provided foundational funding that enabled us to kick-off our next-generation product development. CABHI went beyond what we could have expected by making an introduction to the Ontario Brain Institute that led OBI to provide matching funding. CABHI’s investment and reputation assisted iGuard in securing a cohort position at a large US agetech accelerator.  Lastly, CABHI not only says they are startup-centric, but they lived up to that in their interactions with iGuard.

Rachel Bartholomew

RACHEL BARTHOLOMEW 
CEO & Founder, Hyivy

“The MC2 program from CAHBI came at an important time for Hyivy at a stage where we were ramping up manufacturing, regulatory, clinical trials, and growing our company. They have provided connections, resources, advice, and a handful of opportunities to help us continue on the path of success

Vineet Johnson

VINEET JOHNSON
Founder & CEO, IRegained Inc.

“IRegained Inc. benefited enormously from the MC2 Capital program offered by CABHI. In addition to funding, access to CABHI’s network of mentors and advisors continues to play a significant role in our business development and go-to-market strategies. CABHI’s staff are always accessible and have supported us throughout this journey. I would strongly recommend CABHI to all start-ups operating in this space

ELIZABETH AUDETTE-BOURDEAU
CEO & Co-Founder, Welbi

CABHI and the MC2 Capital program have opened important doors for Welbi. Their large network in the senior living industry has allowed us to accelerate our growth. The CABHI team is always there for us, ready to help, and we are grateful to be part of their portfolio.”

DEREK SHAM
Founder & CEO, Cosm Medical

“CABHI’s MC2 Capital program has been great. We worked together with CABHI on projects including value framework, health economics, and non-dilutive grant funding. I would recommend CABHI to any healthtech startup looking for a value-added investor!

TAHIR  JANMOHAMED
Founder & CEO, ManagingLife

“The MC2 Capital program came at a critical time for ManagingLife, allowing us to maintain momentum in our US commercialization and product development roadmaps. The program team and the advisor network were invaluable in terms of the guidance provided and the connections made.

2022-2023 Key Program Dates

Program applications open

October 3, 2022

Deadline for applications

October 31, 2022

Shortlisted applicants notified

November 7, 2022

Due diligence process 

-Data room review

-Due diligence sessions

space
November 7-8, 2022
November 14-25, 2022

Due diligence process 

Data room review

November 7-8, 2022

Due diligence sessions

November 14-25, 2022

Selected applicants notified

December 5, 2022

Final date for contracts to be signed

December 31, 2022

Program start date

January 2, 2023

Get Started

Please note that applications closed on October 31, 2022.

Subscribe to our newsletter to stay up-to-date on future CABHI program offerings.

Questions about the program? Contact Jesse Mastrangelo at jmastrangelo@cabhi.com.

 

*Please note that companies cannot be awarded under both CABHI’s MC2 Capital Program and the Ontario Brain Institute’s NERVE Program at the same time.

 

Are you an investor? If you’re interested in learning more about investment opportunities with CABHI companies (or those under due diligence), you can request to join CABHI’s investor network here.

Select Partners

National Bank Logo
Berkley Skydeck Logo
SOMPO Digital Lab Logo
Mary Furlong Logo
IBM Logo
Direct Supply Logo
innovacorp logo
Ontario Brain Institute Logo
Seniors Quality Leap Initiative logo
Aging 2.0 logo
NHSA Logo
UHN Logo
Quanta Computer logo
Israel Innovation Authority Logo
Fuji Innovative Spirits Logo
The Society for post acure and long derm care medicine logo
International council on active aging logo
CCNV Logo
mars logo
Hamilton Health Science Logo
Clinical Trials Ontatio Logo
baycrest rotman logo v1
Clearco Logo